News and Opinions - World Stem Cell Summit

Newly discovered mechanism in the cell’s energy factory can lead to new treatment of muscle disorders

by admin | Dec 20, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By University of Copenhagen – Researchers have discovered a mechanism in our cells that is essential to energy production in the muscles. The discovery may lead to new treatment for disorders affecting the muscles, like diabetes, cancer and cardiovascular...

New drug tested to reduce side effect of ‘half-matched’ stem cell transplants

by admin | Dec 19, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Julia Evangelou Strait – WashU Medicine – Clinical trial indicates safety, fewer cases of life-threatening graft-versus-host disease than expected Adding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening side...

Gene and Cell Therapies Take Aim at Parkinson’s Disease

by admin | Dec 18, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Caroline Seydel – Genetic Engineering & Biotechnology News – Parkinson’s disease is characterized by the loss of dopamine-producing neurons. The current treatment is oral levodopa, which is taken up by brain neurons and converted to dopamine. But...

Health Net grant for UC Davis Stem Cell Program to improve access to CAR T-cell therapy

by admin | Dec 17, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Nadine A Yehya – UCDavis Health – Funding promotes local production of CAR T-cell immunotherapy for cancer patients UC Davis Health’s Stem Cell Program has received a $500,000 grant from California health insurer Health Net to improve cancer patients’...

Stem cell therapy TED-A9 showing safety and early efficacy in trial

by admin | Dec 16, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Margarida Maia, PhD – Parkinson’s News Today – The first six Parkinson’s disease patients given the investigational stem cell-based therapy TED-A9 in a clinical trial showed safety and an easing in their symptoms over one year of follow-up, the...

High Response Rate for CAR T-Cell Therapy in Patients With Fast-Growing Leukemia

by admin | Dec 13, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Technology Networks – A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia. Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel...